Sign in →

Test Code LAB90426 Buprenorphine Screen Urine

Reporting Title

Buprenorphine Screen Urine

Methodology

Buprenorphine Enzyme Immunoassay

Roche Diagnostics RMH, BH, DH, DMH, GCMH, GMC, GMH, HMH, MGH, MH, OBH, PMH, SH, WECC, HMH

Siemens Diagnostics:  SH 

Confirmation of presumptive positive screening results may be requested and will be charged as separate tests.

Screening results should be used for medical (e.g., treatment) purposes only

Performing Laboratory

OhioHealth Laboratory Services - RMH, BH, DH, DMH, GCMH, GMC, GMH, HMH, MGH, MH, OBH, PMH, SH, WECC Core Laboratories

Specimen Requirements

35 mL (minimum volume: 2 mL with no possiblity of confirmaiton) from a random urine collection in a screw-top capped, plastic urine container. 

10 mL BD yellow-top round bottom urine tube.

No preservative. 

 

Specimen Stability Information:

Stable 7 days refrigerated

Specimen Transport Temperature

Ambient/Refrigerate OK/ Frozen OK

Reference Values

None Detected

Presumptive positive cutoff concentration 5 ng/mL.

The following information is required for the reporting of toxicology results:

  • Substances or classes of substances analyzed as part of the test
  • Specimen type
  • Report Status for positive results (presumptive positive, confirm if clinically indicated)
  • The assay cut-off concentrations
  • A statement that the results are to be used for medical purposes only

Day(s) Test Set Up

Monday through Sunday

Test Classification and CPT Coding

80307

G0480 x1 (if appropriate)